NASDAQ: MGRX
Mangoceuticals Inc Stock Ownership - Who owns Mangoceuticals?

Insider buying vs selling

Have Mangoceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eugene M. JohnstonCFO2025-12-153,333$1.17
$3.88kSell
Eugene M. JohnstonCFO2025-12-095,000$1.20
$5.98kSell
Eugene M. JohnstonCFO2025-12-0510,000$1.13
$11.28kSell
Alex P. HamiltonDirector2025-11-19125,000$1.22
$152.88kSell

1 of 1

MGRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGRX insiders and whales buy or sell their stock.

MGRX Shareholders

What type of owners hold Mangoceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan Arango4.64%1,000,000$385.00kInsider
Jacob D. Cohen2.81%605,000$232.93kInsider
Amanda Elizabeth Hammer0.81%175,000$67.38kInsider
Lorraine Pamela Dalessio0.63%136,667$52.62kInsider
Kenny Myers0.63%136,667$52.62kInsider
Eugene M. Johnston0.56%120,000$46.20kInsider
Antonios Isaac0.28%60,000$23.10kInsider
Alex P. Hamilton0.02%3,334$1.28kInsider
Citadel Advisors LLC0.00%339$130.52Institution
Citade0.00%339$130.52Institution

1 of 3

MGRX vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGRX0.01%10.37%Net Selling
BFRG0.01%13.32%
ACON0.00%56.96%Net BuyingNet Buying
HCTI0.00%100.00%
MNDR0.01%58.72%Net BuyingNet Buying

Mangoceuticals Stock Ownership FAQ

Who owns Mangoceuticals?

Mangoceuticals (NASDAQ: MGRX) is owned by 0.01% institutional shareholders, 10.37% Mangoceuticals insiders, and 89.62% retail investors. Jonathan Arango is the largest individual Mangoceuticals shareholder, owning 1.00M shares representing 4.64% of the company. Jonathan Arango's Mangoceuticals shares are currently valued at $403.00k.

If you're new to stock investing, here's how to buy Mangoceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.